We present an in-depth analysis of the structural and functional properties of Imperatoxin I (IpTx i ), an ϳ15-kDa protein from the venom of the scorpion Pandinus imperator that inhibits Ca 2؉ release channel/ryanodine receptor (RyR) activity (Valdivia, H. H., Kirby, M. S., Lederer, W. J., and Coronado, R. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 12185-12189). A cDNA library was prepared from the venomous glands of this scorpion and used to clone the gene encoding IpTx i . From a single continuous messenger RNA, the information coding for the toxin is translated into two mature polypeptide subunits after elimination of a basic pentapeptide. The IpTx i dimer consists of a large subunit (104-amino acid residues) with phospholipase A 2 (PLA 2 ) activity covalently linked by a disulfide bond to a smaller (27 amino acid residues), structurally unrelated subunit. Thus, IpTx i is a heterodimeric protein with lipolytic action, a property that is only shared with ␤-bungarotoxins, a group of neurotoxins from snake venoms. The enzymatic subunit of IpTx i is highly homologous to PLA 2 from bee (Apis mellifera) and lizard (Heloderma horridum) venoms. The small subunit has no significant similarity to any other known peptide, including members of the Kunitz protease inhibitors superfamily that target the lipolytic effect of ␤-bungarotoxins. A synthetic peptide with amino acid sequence identical to that of the small subunit failed to inhibit RyR. On the other hand, treatment of IpTx i with p-bromophenacylbromide, a specific inhibitor of PLA 2 activity, greatly reduced the capacity of IpTx i to inhibit RyRs. These results suggested that a lipid product of PLA 2 activity, more than a direct IpTx i -RyR interaction, was responsible for RyR inhibition.
Scorpion venoms contain families of small basic proteins that modify the gating mechanism of Na ϩ channels or block with high affinity K ϩ channels of excitable cells (1, 2) . These toxins have been invaluable tools in the identification, purification, structural mapping, and functional characterization of the corresponding ionic channels. The study of other ionic channels have also been aided by toxins from poisonous animals. For instance, snake venoms contain potent neurotoxins that block acetylcholine receptors (3) , and snail and spider venoms contain small molecular weight proteins directed against neuronal Ca 2ϩ channels (4, 5) . A Cl Ϫ channel-specific blocker peptide was also recently isolated from a scorpion venom (6) . Thus, there exist a vast array of natural ligands useful for structural and functional characterization of ionic channels.
The Ca 2ϩ release channel of SR 1 constitutes the major pathway for Ca 2ϩ release during the process of excitation-contraction coupling in cardiac and skeletal muscle (7) . The Ca 2ϩ release channel binds the plant alkaloid ryanodine with nanomolar affinity, hence the name ryanodine receptor (RyR). Ryanodine has been an invaluable tool in the structural and functional characterization of RyR. The alkaloid binds to a conformationally sensitive domain on the RyR protein and may be used in binding assays as an index of the functional state of the channel (8, 9) . However, ryanodine displays extremely slow dissociation kinetics that make its effect practically irreversible. Furthermore, certain concentrations of ryanodine may open RyRs while others may block them (10) , leading to ambiguous results.
From the venom of the African scorpion Pandinus imperator, we isolated Imperatoxin I (IpTx i ), a ϳ15-kDa protein that inhibited [ 3 H]ryanodine binding to cardiac and skeletal SR by blocking RyR channels (11) . At concentrations well above the half-maximal effective concentrations (ED 50 ) exhibited for RyR, IpTx i did not modify the binding of ligands targeted against other transporters and ionic channels of striated muscle (11) . IpTx i blocked RyR rapidly and reversibly, and when injected in ventricular cells it decreased twitch amplitude and intracellular Ca 2ϩ transients, suggesting a selective blockade of Ca 2ϩ release from the SR (11) . In this study, we carried out an in-depth analysis of the mechanism of action of IpTx i on RyRs of cardiac and skeletal muscle. We determined the complete amino acid and nucleotide sequence of IpTx i and show that, like ␤-bungarotoxins, IpTx i is a heterodimeric protein composed of a high molecular weight subunit with PLA 2 activity and a small, structurally unrelated subunit. We also show that free fatty acids, lipid products of IpTx i -PLA 2 activity, are involved in the inhibition of RyR. IpTx i thus offers an alternative way to block RyR distinct from ryanodine and other ligands that require a physical interaction with the RyR protein.
EXPERIMENTAL PROCEDURES
Chemicals and Reagents-Protease lysine C (Lys-C) and restriction enzymes were from Boehringer Mannheim. Chemicals and solvents for peptide sequencing were from Millipore Co. Primers for polymerase chain reaction (lambda gt11 forward and reverse; 1218 and 1222) and Vent R polymerase were from New England BioLabs. DNA sequencing kit (Sequenase version II), was from U. S. Biochemical Corp. Subcloning and sequencing vector (pBluescript phagemid; pKS), M13 Ϫ20, and M13 reverse sequencing primers were from Stratagene. Brain phosphatidylethanolamine and brain phosphatidylserine were from Avanti Polar Lipids. [ Purification of IpTx i -P. imperator venom was obtained by electric stimulation of scorpions maintained alive in the laboratory. Venom (120 mg per batch) was suspended in double distilled water and centrifuged at 15,000 ϫ g for 30 min. The supernatant was applied onto a column (0.9 ϫ 190 cm) of Sephadex G-50 superfine (Pharmacia Biotech Inc.). Fractions were eluted with 20 mM NH 3 OAc (pH 4.7) at a flow rate of 20 ml/h. Fraction II containing IpTx i was applied to a column (0.9 ϫ 30 cm) of carboxymethyl (CM)-cellulose 32 (Whatman) equilibrated with 20 mM NH 3 OAc (pH 4.7). Peptides were eluted at a flow rate of 20 ml/h with a linear gradient of 250 ml of 20 mM NH 3 OAc (pH 4.7) and 250 ml of the same buffer containing 0.55 M NaCl. Peptides displaying capacity to inhibit [ 3 H]ryanodine binding and phospholipase activity were dialyzed against deionized water (3 ϫ 30 min), concentrated by lyophilization, and injected into a C 4 reverse-phase HPLC column (Vydac). IpTx i was eluted with a linear gradient of 0 -60% acetonitrile in 0.1% trifluoroacetic acid running at 1 ml/min for 60 min. The purity and identity of IpTx i was confirmed by amino acid sequence analysis, as described for Na ϩ channel-blocking peptides (12) . IpTx i was quantified either by amino acid analysis or by absorbance at 280 nm (A 280 nm ) using an extinction coefficient (⑀) ϭ 14,952.
Amino Acid Analysis and Microsequencing of IpTx i -Amino acid analysis was performed on samples hydrolyzed in 6 N HCl with 0.5% phenol at 110°C in evacuated, sealed tubes as described (13) . Reduction of IpTx i with dithiothreitol and alkylation with iodoacetic acid was performed as described (13) . Reduced and alkylated IpTx i was cleaved with protease Lys-C in 200 l of 25 mM Tris-HCl (pH 7.2), and 1.0 mM EDTA, at a enzyme:peptide ratio ϭ 1:100. Microsequence determination of native, reduced, and carboxymethylated toxin, and their peptide fragments was carried out with a 6400/6600 MilliGen/Biosearch Prosequencer, using the peptide adsorbed protocol on CD Immobilon membranes.
Cloning and Sequencing of the cDNA Encoding IpTx i -Two oligonucleotides encoding for two different regions of IpTx i were synthesized as described (13) . Oligonucleotide 1 (5Ј-AC(N)ATGTGGGG(N)AC(N)AA(G/ A)TGGTG-3Ј; where N means any nucleotide) encoded for the first 8 amino acids of the amino terminus of the large subunit of IpTx i . Oligonucleotide 2 (5Ј-GA(G/A)GC(N)GG(N)TA(T/C)GG(N)GC(N)TGGGC-3Ј) encoded for residues 14 -21 of the small subunit. Total RNA was purified from the venomous glands (telsons) of 30 scorpions. The telsons were pulverized in liquid nitrogen and poured into 10 ml of GT buffer (4 M guanidinium isothiocyanate, 0.025 M sodium citrate (pH 7.0), 0.5% N-lauryl sarcosine, and 0.03 M ␤-mercaptoethanol), vortexed, and centrifuged at 5,000 ϫ g for 10 min. One ml of 2 M sodium acetate (pH 4) was added to the recovered supernatant. The resulting solution was extracted with 10 ml of water-saturated phenol plus 2 ml of chloroform: isoamyl alcohol (49:1, v:v), allowing to sit on ice for 15 min. After centrifuging at 10,000 ϫ g for 20 min at 4°C, the aqueous layer was precipitated with 1 volume of isopropyl alcohol, incubated at Ϫ20°C for 1 h, and centrifuged at 10,000 ϫ g for 20 min at 4°C. The pellet was dissolved in 0.3 ml of GT buffer and 0.3 ml of isopropyl alcohol, incubated at Ϫ20°C for 1 h, and pelleted again. The pellet was washed with 95% ethanol, briefly dried under vacuum, and resuspended in RNasefree water. Messenger RNA was purified following the instructions of the Hybond-mAP protocol (messenger affinity paper; Amersham Corp., RPN.1511). cDNA synthesis was performed as described (13) from 5 g of mRNA. The cloning of the cDNA library was also performed as described (13) . The screening of the cDNA library was performed with oligonucleotides 1 and 2 separately, but the clones detected with oligonucleotide 1 were analyzed first. Inserts of cDNA from positive clones were polymerase chain reaction-amplified using gt11 forward and reverse primers. Polymerase chain reaction products were purified from agarose gel and ligated into the EcoRV site of pBluescript (pKS) phagemid. The ligation reactions were used to transform Escherichia coli DH5-␣ cells. Plasmid DNA from white colonies was digested with BamHI and HindIII to verify the size of the original inserts. Clones of interest were sequenced using the Sequenase R kit version 2 (U. S. Biochemical Corp.) on both strands. Oligonucleotides gt11 forward, gt11 reverse, M13 -20, and M13 reverse were used for sequencing.
Sequence Comparisons-The amino acid sequence of the large and small subunits of IpTx i were compared with those of other proteins deposited in the protein data base of GenBank (Los Alamos National Laboratory, Los Alamos, NM) by computer analysis using the program Blitz version 1.5 (Biocomputing Research Unit, University of Edinburgh, UK).
Determination of Phospholipase A 2 Activity-Phospholipase A 2 activity was determined by the titration method of Shiloah et al. (14) , using dilute egg yolk (1:20 in saline solution) as substrate. Liberation of acid was measured at pH 8.0 and 37°C by titration with 5 mM NaOH under a constant stream of N 2 . One unit of enzyme is defined as the amount of enzyme that liberates 1 mol of free fatty acid/min under the above conditions. Inhibition of phospholipase A 2 with pBPB was carried out as described by Díaz et al. (15) . One hundred l of 200 M IpTx i in 35 mM Tris (pH 8.0) were mixed with 10 l of 2 mM p-BPB in acetone and incubated for 16 h at room temperature under dim light. The reaction was stopped by filtration in a Sephadex G-10 column. pBPB-treated IpTx i elutes in the void volume of the column, whereas the excess of pBPB is retarded.
Synthesis of the Small Subunit of IpTx i -The small subunit of IpTx i was synthesized by the solid phase method of Merrifield (16), using t-butyloxycarbonyl-amino acids. This subunit contains a Cys residue at position 4. To avoid formation of inter-peptide disulfide bonds, Cys 4 was substituted by Ala (peptide A), Met (peptide M), or Cys (peptide C) protected with 3-nitro-2-pyridinesulfonyl (thiol-protecting group that will not allow formation of disulfide bonds). At the end of the synthesis all three peptides were separated in a C 18 reverse-phase HPLC column, using the conditions described above. The purity of the synthetic peptides was confirmed by both amino acid analysis and microsequencing, as described above.
[ 4 Ci/mmol) was diluted directly in the incubation medium to a final concentration of 7 nM. Protein concentration was 0.2-0.4 and 0.3-0.5 mg/ml for skeletal and cardiac SR, respectively. Samples were filtered on Whatman GF/B glass fiber filters and washed twice with 5 ml of distilled water. A Brandel M24R cell harvester was used for filtration. Nonspecific binding was determined in the presence of 10 M unlabeled ryanodine and has been subtracted from each sample.
Planar Bilayer Technique-Recording of single RyR in lipid bilayers was performed as described previously (17) . Briefly, a phospholipid bilayer of phosphatidylethanolamine:phosphatidylserine (1:1 dissolved in n-decane to 20 mg/ml) was formed across an aperture of ϳ300 m diameter in a delrin cup. The cis chamber (900 l) was the voltage control side connected to the head stage of a 200 A Axopatch amplifier, and the trans chamber (800 l) was held at virtual ground. Both chambers were initially filled with 50 mM cesium methane sulfonate and 10 mM Tris/Hepes (pH 7.2). After bilayer formation, cesium methane sulfonate was raised to 300 mM in the cis side, and 100 -200 g of SR vesicles were added. After detection of channel openings, Cs ϩ in the trans chamber was raised to 300 mM to collapse the chemical gradient. Single channel data were collected at steady voltages (Ϫ30 mV) for 2-5 min. Channel activity was recorded with a 16-bit VCR-based acquisition and storage system at a 10-kHz sampling rate. Signals were analyzed after filtering with an 8-pole Bessel filter at a sampling frequency of 1.5-2 kHz. Data acquisition and analysis were done with Axon Instruments software and hardware (pClamp v6.0, Digidata 200 AD/DA interface). (Fig. 1B) . The fraction containing IpTx i (indicated by the arrow) eluted early in the run, when the concentration of NaCl was ϳ160 mM. Fig. 1C shows the chromatographic profile of IpTx i after elution from a reverse-phase C 4 HPLC column. Only a minor contaminant was present (labeled with asterisk), which was discarded for further studies of IpTx i structure. However, amino acid sequence analysis of purified IpTx i yielded two different amino acids per reaction cycle, with an apparent equivalent stoichiometry. This indicated either that a contaminant was still present at the end of our purification procedure or that IpTx i was composed of two different peptide subunits.
RESULTS

Purification of IpTx i -Purification
We determined the dose-response relationship for each of the active venom components to assess their potency to inhibit RyRs (Fig. 1D ). Whole P. imperator venom and fraction 2 inhibited [ 3 H]ryanodine binding to cardiac SR with a concentration of 20.2 and 4.3 g/ml, respectively, yielding the half-maximal effect (IC 50 ); IC 50 for pure IpTx i was 0.7 g/ml. Based on this value and the molecular mass of IpTx i (ϳ15 kDa), the estimated apparent dissociation constant (K d ) was 46 nM. Essentially identical results were obtained when skeletal SR was used for displacement studies (not shown).
Electrophoretic Analysis of IpTx i -To elucidate whether IpTx i was composed of two subunits, an aliquot of IpTx i was reduced and alkylated. The modified toxin was then chromatographed in a Bio-Gel P30 column ( Fig. 2A) to eliminate reaction by-products and excess of reagents. Three peaks were obtained ( Fig. 2A ) and analyzed by SDS-PAGE (Fig. 2B ). Peak 1 (labeled Red, abbreviation for reduced) had lower molecular mass than native IpTx i (labeled Nat); peak 2 could not be resolved in the same gel (not shown), but direct sequencing indicated that it corresponds to a ϳ3-kDa peptide (Fig. 3A) ; peak 3 was not peptidic in nature, indicating that it corresponded to the reducing and alkylating reagents. Fig. 2C shows that the apparent molecular mass of native IpTx i was ϳ15 kDa and that of the reduced IpTx i was ϳ12 kDa. Thus, treatment of IpTx i with thiol-reducing agents separates a large (ϳ12 kDa) from a small (ϳ3 kDa) subunit.
Peptide Sequence Determination-The reduced and alkylated derivatives of IpTx i (peak 1 and 2 of Fig. 2A ) were sequenced by direct Edman degradation. As shown in Fig. 3A , we identified the first 27 amino acid residues of the large subunit, and all 28 amino acid residues of the small subunit. To identify the remaining residues, the large subunit was cleaved with Lys-C endopeptidase, which yielded three peptide fragments that eluted with different retention times in an HPLC column (data not shown). The amino acid sequence of each of these peptides, obtained also by Edman degradation, is underlined in Fig. 3A .
Cloning and Sequencing of the cDNA Encoding IpTx i -Two oligodeoxynucleotides synthesized according to the amino acid sequence of stretch 1-8 of the large subunit and stretch 14 -21 of the small subunit were used to screen a cDNA library, constructed from the venomous glands of P. imperator scorpi- . A linear gradient of sodium chloride resolved 5 subfractions, the first of which (indicated by the arrow) contained IpTx i . C, the subfraction from the CM-cellulose column containing IpTx i was lyophilized and injected into a C 4 reverse-phase HPLC column and eluted with a 0 -100% linear gradient of acetonitrile containing 0.1% trifluoroacetic acid. The peak labeled with an asterisk was not studied further. D, dose-response curve for whole venom and purified components. [ 3 H]Ryanodine (7 nM) was incubated with cardiac SR protein in 0.2 M KCl, 10 M CaCl 2 , 10 mM Na-Hepes (pH 7.2) in the absence (control, 100%) and the presence of indicated concentrations of venom components. Nonspecific binding was determined in the presence of 20 M ryanodine and has been subtracted from this and subsequent results.
ons. These oligodeoxynucleotides were used as probes to isolate a full-length IpTx i cDNA clone. Both probes led to the isolation of the same cDNA clone. Its complete nucleotide sequence is shown in Fig. 3B . This sequence contained an open reading frame of 167 amino acids encompassing 1) a putative signal peptide (first underlined 31 amino acids, positions Ϫ31 to Ϫ1); 2) the mature ϳ12-kDa, large subunit of IpTx i (104 amino acids, positions 1-104); 3) a putative connector pentapeptide (RRLAR, positions 105-109); and 4) the mature small subunit (27 amino g) was reduced and alkylated as described under "Experimental Procedures," applied to a Bio-Gel P30 column (0.9 ϫ 27 cm), and eluted with 10% acetic acid. Peak 1 corresponds to a ϳ12-kDa peptide, peak 2 to a ϳ3-kDa peptide (determined by direct sequencing), and peak 3 to reaction by-products. B, SDS-PAGE analysis of 3 g of native IpTx i (Nat) and 3 g of peak 1 (Red). Gel was 10% polyacrylamide. Proteins were stained with Coomassie Blue. The running gel (R.G.) and the tracking dye (T.D.) positions are indicated by arrows. C, the retention factor (R f ) for various molecular weight markers is plotted as a function of log 10 molecular weight (M.W.). The apparent molecular weight for native and reduced IpTx i was extrapolated from a linear regression to the data points.
FIG. 3. Amino acid and nucleotide sequences of IpTx i .
A, the complete amino acid sequence of IpTx i was obtained from direct Edman degradation using peak 1 (large subunit) and peak 2 (small subunit) of Fig. 2A (labeled d) and from proteolytic fragments (lc 1 , lc 2 , and lc 3 ) of peak 1. To obtain the proteolytic fragments, peak 1 (100 g) was incubated for 4 min at 36°C with 1 g of Lys-C endopeptidase in Tris buffer as specified in the Boehringer catalog. The reaction products were separated by HPLC, essentially as described in the legend to 
Lack of Inhibition by the Short Subunit of IpTx i -We
Reduced and carboxymethylated small subunit (peak 2 of Fig.  2A ), at concentrations up to 15 M, had no effect on the binding of To discard the presence of spurious reagents as being the cause of negative results, we synthesized the small subunit in three distinctive forms as follows: peptide C was similar to the native small subunit, and peptides A and M were also similar to the native small subunit, except that Cys 4 was substituted by Ala and Met, respectively. This avoided the formation of interpeptide disulfide bridges caused by oxidation of Cys 4 . The three peptides were HPLC-purified before testing. Table I (19) .
The Phospholipase A 2 Activity of IpTx i Is Important to Inhibit RyR-We next investigated if the large subunit of IpTx i , or its enzymatic activity, was involved in RyR inhibition. The reduced and carboxymethylated form of the large subunit of IpTx i (peak 1) was incapable of inhibiting [ 3 H]ryanodine binding to cardiac or skeletal RyR. However, this was expected given that internal disulfide bridges are essential for preservation of the toxin's tridimensional structure as well as for expression of its enzymatic activity (20) . We thus resorted to pBPB, a covalent modifier of His residues that specifically blocks phospholipase A 2 activity (15) without affecting disulfide bonds. The rate of fatty acid liberation by 1 mol of IpTx i was 384 Ϯ 26 and 41 Ϯ 12 mol min Ϫ1 in control and after incubation with pBPB, respectively (n ϭ 4; data not shown). Thus, treatment of IpTx i with pBPB decreased substantially its PLA 2 activity. Fig. 5 shows that pBPB-treated IpTx i decreased dramatically its capacity to inhibit the binding of ]. In cardiac SR (Fig. 6, right panel) cles-The membranes of SR vesicles contain different classes of phospholipids that may serve as substrates for the PLA 2 activity of IpTx i . We reasoned that if the inhibitory properties of IpTx i were at least partly due to its enzymatic activity, then inhibition should be observed by incubating RyR with supernatant of IpTx i -treated SR vesicles. Control SR vesicles were diluted in binding medium to 1 mg/ml and incubated at 36°C with 100 nM IpTx i . After 30 min, the IpTx i -treated SR vesicles were pelleted at 32,000 ϫ g for 15 min, and a clear supernatant was obtained. The supernatant was then tested for its capacity to inhibit the binding of [ 3 H]ryanodine binding assay followed changes in channel gating (8 -10, 17, 21) , the changes described above suggest that IpTx i released a phospholipid product that bound to RyRs (or a closely associated regulatory protein) and decreased open probability (p o ); after removal of the phospholipid product, p o could recover to control levels.
Single Channel Effects of IpTx i -To test directly the above hypothesis and to gain insight on the manner in which IpTx i inhibits RyRs, we reconstituted swine cardiac RyR in planar lipid bilayers, as described (11, 17) . Fig. 9 shows traces from continuous recording at Ϫ30 mV holding potential in the absence (control) and the presence of increasing concentrations of IpTx i . Channel activity was monitored over 80 s in each condition, and the mean p o was obtained from current histograms. Inhibition of RyR by Fatty Acids-PLA 2 catalyzes the hydrolysis of the S n 2 fatty acyl bond of phospholipids to release free fatty acids and lysophospholipids (22) . We tested the effect of each of these lipids separately on RyR activity. Fig. 10A shows that lysophosphatidylcholine (lyso-PC), at concentrations up to 300 M, does not modify substantially the open lifetime or the unitary conductance of cardiac RyR. On the other hand, linoleic acid, an 18-carbon unsaturated fatty acid, blocks RyR at lower concentrations and in a manner that is reminiscent of the blockade produced by IpTx i . Addition of 30 M linoleic acid to the cytosolic face of the channel decreases the lifetime and the frequency of open events; similar to IpTx i , the fatty acid induces the appearance of openings that are too fast to be resolved by our recording bandwidth.
The potency of several fatty acids to inhibit RyRs was determined by their capacity to inhibit [ 3 H]ryanodine binding to cardiac SR vesicles (Fig. 10B) . Palmitic acid, a 16-carbon saturated fatty acid, partially inhibited RyR but at concentrations Ն100 M. Arachidonic acid, linoleic acid, and oleic acid, unsaturated fatty acids abundant in SR membranes of cardiac and skeletal muscle (23) , totally inhibited RyR with an IC 50 ϭ 25, 55, and 70 M, respectively. In agreement with single channel results, lyso-PC and lysophosphatidylethanolamine were unable to modify [ 3 H]ryanodine binding. Thus, not all PLA 2 products are capable of inhibiting RyRs. Among the fatty acids, the potency to inhibit RyRs increases with the carbon chain length and the number of unsaturations.
DISCUSSION
In the present study, we determined the complete amino acid and nucleotide sequence of IpTx i , a heterodimeric protein from the venom of the scorpion P. imperator, and unraveled the molecular mechanism by which it inhibits RyRs of cardiac and skeletal muscle.
The deduced amino acid sequence from the cDNA encoding IpTx i and the amino acid sequence determined by Edman degradation strongly suggests that IpTx i is synthesized as a precursor of the pre-pro form. Putative signal and connector peptides must be removed to produce mature IpTx i . The proposed signal peptide does have a large content of acidic residues (8 out of the last 18 residues are acidic), a property that is rarely seen in signal peptides. For this reason, we cannot exclude whether the proposed signal peptide codes for another peptide before coding for the large subunit of IpTx i . Regarding the connecting pentapeptide Arg-Arg-Leu-Ala-Arg (positions 105 to 109 in the cDNA sequence of Fig. 3 ), we gather that several enzymes must be required to eliminate it from the mature protein.
Initially, a cleavage must occur at Arg 109 (monobasic site), as it occurs in the maturation of prosomatostatin and other prohormones (24) . Two characteristics distinguish this cleavage site and both are present in the cDNA of IpTx i : (i) Arg (or other basic residue) is immediately preceded by Ala or Leu (or both); (ii) Arg is located three or five residues upstream the basic amino acid involved in the cleavage. Next, another cleavage must occur at Arg 106 (dibasic site) as is the case during the maturation of diverse peptidic hormones (25) . A third enzyme with carboxypeptidase activity must intervene to remove Arg 105 and Arg 106 . Because of this complicated pattern of maturation, we assume that the linking of the small and large subunit of IpTx i must be important for the function of IpTx i .
Mature IpTx i is composed of a ϳ3-kDa peptide covalently linked to a ϳ12-kDa peptide with PLA 2 activity. The large subunit of IpTx i conserves the most important substructures of secreted PLA 2 from group III (Fig. 4) . The His/Asp pair, essential for Ca 2ϩ binding, is in position 33/34 of IpTx i and is preceded in the three PLA 2 s by a Cys-Cys-Arg motif; the amino terminus (roughly residues 4 -12 of IpTx i ), presumably involved in substrate binding, is also highly conserved in the three PLA 2 s; lastly, the Cys residues, essential for maintaining proper folding through disulfide bonds, may be used in this group as the elemental frame to align homologous sequences and to identify stretches of sequence that have been inserted or deleted through evolution. Only Cys 101 of IpTx i (relative position 104 in Fig. 4 ) does not match with Cys residues present at the carboxyl terminus of the other PLA 2 shown. It is likely, therefore, that Cys 101 is involved in the disulfide bridging with Cys 4 of the small subunit. The presence in IpTx i of a PLA 2 subunit covalently linked to a small, structurally unrelated peptide is reminiscent of the bipartite arrangement of ␤-bungarotoxins (26), a group of snake neurotoxins that inhibit neurotransmitter release (27) . Each ␤-bungarotoxin dimer has a PLA 2 subunit covalently bound to a smaller subunit related to Kunitz-type protease inhibitors. Members of the Kunitz superfamily bind to and block voltage-dependent K ϩ and Ca 2ϩ channels (28) . Thus, although the small subunit of IpTx i showed no homology to members of the Kunitz superfamily, its distinctive arrangement within the toxin suggested that it might act as a blocker. For this reason, it was surprising at first to realize that the small subunit was not directly responsible for inhibiting RyRs. Direct addition of the small subunit to our [ 3 H]ryanodine binding assays failed to inhibit RyRs, as did a synthetic peptide with amino acid sequence similar to that of the small subunit and two additional derivatives designed to avoid interpeptide disulfide bridge formation (Table I) . Hence, the target site for the small subunit, or its biological function, remains to be determined.
Given our failure to detect inhibition by the small subunit, we turned our attention to the large subunit of IpTx i . In a reduced and carboxymethylated form, the large subunit of IpTx i failed to inhibit RyRs (not shown). However, this was not surprising given that disulfide bridges are essential to maintain the toxin's three-dimensional structure (20) . It was the treatment of IpTx i with pBPB, a covalent modifier of His residues that inhibits PLA 2 activity without affecting disulfide bridges (15) , that decreased substantially the capacity of IpTx i to inhibit RyRs (Fig. 5) . This suggested that a lipid product of PLA 2 activity was involved in the inhibition of RyRs. Three separate lines of evidence supported this notion. 1) Inhibition of RyR by IpTx i was favored by the presence of Ca 2ϩ (Ն1 M; Fig.  6 ), as expected from the Ca 2ϩ dependence of enzymatic activity of PLA 2 from group III and several other groups (20) .
2) The supernatant of IpTx i -treated SR vesicles could inhibit RyRs even before IpTx i was present in a concentration large enough to do so (Fig. 7) ; this indicated that RyR inhibition was brought about by a lipid product of IpTx i released from SR vesicles during the incubation period.
3) The kinetics of RyR inhibition by IpTx i were mimicked by direct addition of linoleic acid (but not of lyso-PC) to the cytoplasmic side of the channel (Figs. 9 and 10); other long chain, unsaturated fatty acids could also inhibit RyRs (Fig. 10) . Thus, a potential scenario for inhibition of RyR by IpTx i is as follows: in the presence of micromolar [Ca 2ϩ ], the large subunit of IpTx i catalyzes the hydrolysis of the S n 2 fatty acyl bond of the phospholipids of the SR membrane. The reaction yields free fatty acids and lysophospholipids; the former are released into the incubation medium, and the latter may be liberated or remain embedded into the SR membrane. Free fatty acids bind to RyR or to a closely associated protein that controls gating. At low concentrations, they produce an incomplete block of RyR; higher concentrations gradually block the RyR completely, giving rise to the doseresponse relationship of channel activity and PLA 2 s are abundant components of snakes, scorpions, and bee venoms and often constitute the main toxic component to mammals. Although all PLA 2 s induce a variety of pathological symptoms including neurotoxicity and myotoxicity (29) , they differ in their mechanism of action and in their molecular targets. For example, the snake neurotoxin crotoxin is composed of a PLA 2 subunit and an inhibitory subunit, which keeps the phospholipase inactive until binding to a presynaptic receptor triggers the dissociation of the inhibitory subunit (30) . In contrast, notexin from Netechis scutatus scutatus is a PLA 2 without an associated subunit that produces muscle paralysis by binding to a specific receptor in the neuromuscular junction (31) . IpTx i is the first example of a scorpion toxin in which a PLA 2 is found chaperoned by a smaller, structurally unrelated subunit. In a previous study (11), we found that several transporters and ion channels of striated muscle including the inositol trisphosphate receptor, the muscarinic receptor, voltagesensitive Na ϩ channels, and the Ca 2ϩ -ATPase of SR were insensitive to micromolar concentrations of IpTx i . These results argue against an indiscriminate effect on key molecules of excitation-contraction coupling by the lipolytic action of IpTx i . However, an important question that still remains to be answered concerns the presence of the small subunit of IpTx i . What is its molecular target? What function does it perform to enhance the PLA 2 activity or to suppress it while in transit to the specific receptor? Regardless of the primary site affected, a major contribution of this study was to establish the fact that the molecular mechanism involved in the toxicity of IpTx i will most likely involve abnormalities in intracellular Ca 2ϩ mobilization due to blockade of RyRs.
